Literature DB >> 34160736

Is white the right light for the clinical electrooculogram?

Paul A Constable1, Garima Kapoor2.   

Abstract

PURPOSE: To investigate if a lower luminance monochromatic LED stimulus could be used as an alternative to a high luminance white light for the clinical electrooculogram.
METHODS: Clinical electrooculograms were recorded in color normal participants (N = 23) aged 22.6 ± 1.2 years, 7 male and 16 female using the standard 100 cd.m-2 white illuminant and four monochromatic LEDs with peak wavelengths of 448, 534, 596 and 634 nm at 30 cd.m-2. Pupils were dilated and there was a 30 cd.m-2pre-adaptation to white light for 2 min followed by 15 min dark adaptation and 20 min recording in the light stimulus using a Ganzfeld stimulator.
RESULTS: The normalized LP:DTratio for the short wavelength LED (448 nm) was equivalent in amplitude and timing to the ISCEV standard EOG (p = .99). The LP:DTratio for the white (100 cd.m-2) and 448 nm (30 cd.m-2) were (median ± SEM): 2.49 ± .11 and 2.47 ± .11. The time to light-rise peak was also equivalent being 9.0 ± .2 and 8.0 ± .4 min (p = .54).
CONCLUSIONS: Consideration may be given to using a short wavelength monochromatic stimulus that is more comfortable for the subject than the current 100 cd.m-2 illuminant.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Light-rise; Luminance; Patient comfort; Spectral; Wavelength

Mesh:

Year:  2021        PMID: 34160736     DOI: 10.1007/s10633-021-09845-9

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  45 in total

1.  Some observations on the relationship between the standing potential of the human eye and the bleaching and regeneration of visual purple.

Authors:  G B ARDEN; J H KELSEY
Journal:  J Physiol       Date:  1962-05       Impact factor: 5.182

Review 2.  Bestrophins and retinopathies.

Authors:  Qinghuan Xiao; H Criss Hartzell; Kuai Yu
Journal:  Pflugers Arch       Date:  2010-03-28       Impact factor: 3.657

3.  The effects of gender and age on the range of the normal human electro-oculogram.

Authors:  Alisa T Thavikulwat; Patrick Lopez; Rafael C Caruso; Brett G Jeffrey
Journal:  Doc Ophthalmol       Date:  2015-10-16       Impact factor: 2.379

Review 4.  The electro-oculogram.

Authors:  Geoffrey B Arden; Paul A Constable
Journal:  Prog Retin Eye Res       Date:  2006-03       Impact factor: 21.198

5.  New clinical test of retinal function based upon the standing potential of the eye.

Authors:  G B Arden; A Barrada; J H Kelsey
Journal:  Br J Ophthalmol       Date:  1962-08       Impact factor: 4.638

6.  Comparing Short-Duration Electro-Oculograms with and without Mydriasis in Healthy Subjects.

Authors:  C Türksever; S Orgül; M G Todorova
Journal:  Klin Monbl Augenheilkd       Date:  2015-04-22       Impact factor: 0.700

Review 7.  A meta-analysis of clinical electro-oculography values.

Authors:  Paul A Constable; David Ngo; Stephen Quinn; Dorothy A Thompson
Journal:  Doc Ophthalmol       Date:  2017-10-10       Impact factor: 2.379

8.  BESTROPHINOPATHY: A Spectrum of Ocular Abnormalities Caused by the c.614T>C Mutation in the BEST1 Gene.

Authors:  Lisa Toto; Camiel J F Boon; Luca Di Antonio; Maurizio Battaglia Parodi; Rodolfo Mastropasqua; Ivana Antonucci; Liborio Stuppia; Leonardo Mastropasqua
Journal:  Retina       Date:  2016-08       Impact factor: 4.256

9.  Expression of bestrophin-1, the product of the VMD2 gene, modulates voltage-dependent Ca2+ channels in retinal pigment epithelial cells.

Authors:  Rita Rosenthal; Benjamin Bakall; Tyson Kinnick; Neal Peachey; Sönke Wimmers; Claes Wadelius; Alan Marmorstein; Olaf Strauss
Journal:  FASEB J       Date:  2005-11-10       Impact factor: 5.191

10.  ISCEV Standard for clinical electro-oculography (2017 update).

Authors:  Paul A Constable; Michael Bach; Laura J Frishman; Brett G Jeffrey; Anthony G Robson
Journal:  Doc Ophthalmol       Date:  2017-01-21       Impact factor: 2.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.